Enzyme-Linked Immunosorbent Assay (ELISA) Market to Reach US$ 3.35 Billion by 2031, Fueled by Precision Diagnostics and Next-Gen Automation | QuidelOrtho Corporation, Biomerieux S.A, Gemelli Biotech, ZEUS Scientific, Enzo Biochem Inc

The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at US$ 2.14 billion in 2023 and is projected to reach approximately US$ 3.35 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period from 2024 to 2031.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/enzyme-linked-immunosorbent-assay-market?sg

Enzyme Linked Immunosorbent Assay Market Key Drivers:
Rising Prevalence of Chronic and Infectious Diseases
The global surge in conditions such as cancer, HIV/AIDS, hepatitis, and autoimmune disorders has led to increased demand for accurate and sensitive diagnostic assays like ELISA. The ability of ELISA to detect even minute concentrations of antigens or antibodies makes it indispensable in disease diagnosis and monitoring.

Growth in Biomarker Discovery and Personalized Medicine
The trend toward personalized healthcare has amplified the importance of early and precise detection tools. ELISA tests are extensively used in biomarker validation, helping clinicians tailor treatments based on individual patient profiles.

Technological Advancements in Assay Design
Continuous improvements in assay formats, such as multiplex ELISA and portable microplate readers, have enhanced test throughput and sensitivity. Automation and integration with digital platforms are further reducing human error and improving workflow efficiency in diagnostic laboratories.

Expansion of Clinical Laboratories and Point-of-Care Testing
Increasing investments in diagnostic laboratory infrastructure, especially in emerging economies, are broadening the reach of ELISA testing. The rise of point-of-care testing in rural and remote areas is also expanding market scope, enabling rapid screening and timely intervention.

Regulatory Support and Public Health Initiatives
Government programs focused on infectious disease control, vaccination coverage, and health surveillance have boosted the adoption of immunoassays. Funding and partnerships supporting research and diagnostics are further accelerating ELISA market growth.

Enzyme Linked Immunosorbent Assay Market - Geographical Share:

The ELISA market exhibits strong performance across major global regions, with North America currently holding the largest market share. This dominance is primarily attributed to advanced healthcare infrastructure, widespread adoption of diagnostic tools, and high incidence rates of chronic and infectious diseases. The United States, in particular, accounts for a significant portion of regional revenue due to its early adoption of precision diagnostics and strong investment in immunological research.

Europe follows closely, driven by well-established laboratory facilities, robust regulatory support for diagnostic innovation, and increasing healthcare expenditures. Countries like Germany, the UK, and France are at the forefront of diagnostic advancements and clinical trials, further fueling regional growth.

The Asia-Pacific region is witnessing the fastest growth, supported by expanding healthcare access, rising awareness about early disease detection, and government-led screening initiatives. Nations such as China, India, and Japan are investing heavily in biotechnology and public health programs, propelling the demand for ELISA-based testing solutions.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/enzyme-linked-immunosorbent-assay-market?sg

Strategic Players Driving the Enzyme Linked Immunosorbent Assay Market: Thermo Fisher Scientific, Inc., American Laboratory Products Company (ALPCO), ZEUS Scientific, Inc., Life Technologies Corporation, Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, Biomerieux S.A., Gemelli Biotech, BD and Enzo Biochem Inc.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.